Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112125943A details a novel hypochlorite oxidation method to remove Impurity H, ensuring >99.5% purity for corticosteroid API manufacturing.
Novel patent CN108069831A enables high-purity 2,3-dimethyl-4-fluorophenol production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN112638885B reveals a novel valsartan synthesis avoiding NDMA impurities. This method ensures high purity and supply chain reliability for global pharmaceutical manufacturers.
Advanced two-step synthesis for 2-phenylpropionic acid ensures high purity and cost efficiency for pharmaceutical intermediate supply chains globally.
Patent CN102180892A details a novel purification method enhancing purity and yield. This offers significant supply chain stability and cost reduction in API manufacturing.
Novel resolution method for high-purity pharmaceutical intermediates. Cost-effective scale-up and supply chain reliability for kinase inhibitor synthesis.
Patent CN101701222B reveals a robust enzymatic route for (R)-mandelic acid, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.
Novel hydrolysis-esterification route for high-purity Cefathiamidine. Reduces costs and improves supply chain stability for pharmaceutical manufacturers.
Patent CN111807990A reveals a one-pot method for trifloxystrobin intermediates. Achieve high purity and cost reduction in agrochemical manufacturing with scalable processes.
Novel triazole IDO inhibitor synthesis patent CN109748911A offers improved yield and purity for pharmaceutical intermediate manufacturing supply chains globally.
Patent CN106748888B reveals a safer route for sitagliptin intermediates. Reduces explosive risks and costs for reliable pharmaceutical intermediate suppliers.
Patent CN101386588B reveals a low-temperature isomerization method for high-purity cilastatin acid intermediates, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Advanced synthesis of tulathromycin metabolite standard. Ensures food safety compliance and supply chain reliability for global veterinary pharmaceutical manufacturers.
Patent CN114686465A reveals a hydrolase method for (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, offering green, high-yield production for reliable supply chains.
Patent CN101289456B details enzymatic hydrolysis for higher yield and stability. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN104119326B reveals high-purity Azilsartan synthesis via DMF hydrolysis. Offers significant yield improvements and supply chain stability for global buyers.
Patent CN102351849B reveals a novel one-pot synthesis for Olmesartan Medoxomil intermediates, offering high purity, reduced operational complexity, and scalable manufacturing solutions.
Novel process for pyrido-benzazepine intermediates via glutaraldehyde cyclization. Enhances purity and scalability for ACE inhibitor production.
Patent CN115626893B reveals a cost-effective synthesis route for 2-hydroxy-5-hydroxymethylpyridine, offering significant supply chain and purity advantages for global manufacturers.
Patent CN104592213A reveals a high-yield route for Olmesartan intermediates, offering cost reduction and supply chain reliability for global API manufacturers.